FDG (18 F)
R2IBF serves about 50% of Brazil's territory with FDG (18 F).
Source: LinkedIn company description · Retrieved October 13, 2026
R2IBF develops, produces, and supplies radiopharmaceuticals in support of nuclear medicine in Brazil.
R2IBF has a dedicated team for research, development, and innovation of new radiopharmaceuticals.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
R2IBF serves hospitals and clinics daily in 13 Brazilian states.
R2IBF serves about 50% of Brazil's territory with FDG (18 F).
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 4, 2026, September 14, 2026 and September 16, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.